methotrexate has been researched along with Macrophage Activation Syndrome in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, A; Bossard, C; Bouabdallah, K; Bounaix, L; Choquet, S; Dulery, R; Fornecker, LM; Gabellier, L; Gastinne, T; Houot, R; Laghmari, O; Le Gouill, S; Leux, C; Llamas-Gutierrez, F; Mohty, M; Oberic, L; Parrens, M; Rohmer, J; Roland, V; Sanhes, L; Sarkozy, C; Szablewski, V; Traverse-Glehen, A; Villemagne, B | 1 |
| Fujita, N; Hashimoto, K; Horikoshi, H; Horiuchi, Y; Itoh, K; Kaneko, M; Kawamura, Y; Kimata, M; Kimura, F; Makino, A; Obuchi, Y; Ono, Y; Sano, A; Tanaka, Y | 1 |
| Gao, C; Li, C; Qin, A; Sun, J | 1 |
| Kato, H; Kohsaka, H; Misumi, K; Suzuki, M | 1 |
| Kim, S; Lenert, A; Oh, G; Ombrello, MJ | 1 |
| Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N | 1 |
| Hachulla, E; Hatron, PY; Launay, D; Leurs, A; Quartier, P; Terriou, L | 1 |
| Agarwal, A; Guleria, S; Jindal, AK; Naseem, S; Ratho, RK; Sharma, S; Singh, MP; Suri, D | 1 |
| Giacomelli, R; Ruscitti, P; Shoenfeld, Y | 1 |
| Atzeni, F; Cantatore, FP; Caso, F; Ciccia, F; Cipriani, P; Giacomelli, R; Iacono, D; Liakouli, V; Pantano, I; Perosa, F; Ruscitti, P; Scarpa, R | 1 |
| Komagata, Y | 1 |
| Chakrabartty, J; Jain, N; Sengupta, J; Sinha, R | 1 |
| Abe, I; Akamine, M; Hamasaki, H; Haranaka, M; Ishii, K; Iwakura, M; Maeshima, K; Tatsukawa, H; Yoshimatsu, H | 1 |
| Abrams, K; Berkun, Y; Brik, R; Brunner, HI; Calvo, I; Cimaz, R; Constantin, T; Erguven, M; Ferrandiz, MA; Flato, B; Gamir, ML; Goffin, L; Grom, A; Hofer, M; Horneff, G; Kallinich, T; Kasapcopur, O; Kim, D; Kone-Paut, I; Lheritier, K; Lovell, DJ; Magnusson, B; Martini, A; McCann, L; Nistala, K; Oliveira, SK; Ozen, S; Quartier, P; Ruperto, N; Rutkowska-Sak, L; Schneider, R; Sztajnbok, F; Uziel, Y; Viola, S; Wouters, C; Wulffraat, N | 1 |
4 review(s) available for methotrexate and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Bibliometrics analysis on the research status and trends of adult-onset Still's disease: 1921-2021.
Topics: Bibliometrics; Humans; Macrophage Activation Syndrome; Methotrexate; Prognosis; Still's Disease, Adult-Onset; United States | 2022 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms | 2021 |
A comprehensive review on adult onset Still's disease.
Topics: Adaptive Immunity; Adrenal Cortex Hormones; Age of Onset; Animals; Arthritis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Disease Models, Animal; Ferritins; Humans; Immunity, Innate; Macrophage Activation Syndrome; Methotrexate; Still's Disease, Adult-Onset; Survival Analysis; Young Adult | 2018 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome and
Topics: Antirheumatic Agents; Connective Tissue Diseases; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; gamma-Globins; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Methotrexate; Methylprednisolone; Pulse Therapy, Drug | 2013 |
1 trial(s) available for methotrexate and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Juvenile; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Infections; Interleukin-1beta; Kaplan-Meier Estimate; Macrophage Activation Syndrome; Male; Methotrexate; Neutropenia; Thrombocytopenia | 2012 |
9 other study(ies) available for methotrexate and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Macrophage Activation Syndrome; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2022 |
Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Disseminated Intravascular Coagulation; Female; Humans; Interleukin-18; Macrophage Activation Syndrome; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Still's Disease, Adult-Onset; Treatment Outcome | 2022 |
Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Female; Humans; Lymphoproliferative Disorders; Macrophage Activation Syndrome; Methotrexate; Middle Aged | 2023 |
Clinical characteristics and comorbidities in adult-onset Still's disease using a large US administrative claims database.
Topics: Adult; Comorbidity; Databases, Factual; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Macrophage Activation Syndrome; Male; Methotrexate; Middle Aged; Respiratory Distress Syndrome; Still's Disease, Adult-Onset; United States | 2020 |
Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antineoplastic Agents; Arthritis, Juvenile; Biological Products; Disease Progression; Drug Resistance, Multiple; Female; Glucocorticoids; Humans; Macrophage Activation Syndrome; Medication Therapy Management; Methotrexate; Monitoring, Immunologic; Remission Induction; Young Adult | 2019 |
Adult-Onset Still Disease and Macrophage Activation Syndrome Following Chikungunya and Hepatitis E Coinfection.
Topics: Adolescent; Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin M; Macrophage Activation Syndrome; Methotrexate; Prednisolone; Serologic Tests; Still's Disease, Adult-Onset; Treatment Outcome | 2018 |
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biological Products; Cohort Studies; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Macrophage Activation Syndrome; Male; Methotrexate; Middle Aged; Motivation; Practice Patterns, Physicians'; Sex Factors; Still's Disease, Adult-Onset; Treatment Failure; Tumor Necrosis Factor Inhibitors; Young Adult | 2020 |
A rare case of myelofibrosis secondary to juvenile idiopathic arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Humans; Knee Joint; Macrophage Activation Syndrome; Male; Methotrexate; Primary Myelofibrosis; Ultrasonography | 2016 |
Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.
Topics: Adolescent; Drug Synergism; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Macrophage Activation Syndrome; Methotrexate; Receptors, Tumor Necrosis Factor; Remission Induction; Still's Disease, Adult-Onset | 2012 |